ME Therapeutics Holdings Inc. Stock Deutsche Boerse AG
Equities
Q9T
CA5527671054
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.52 EUR | +7.69% |
|
0.00% | +278.95% |
1 day | +7.69% | ||
Current month | +7.69% | ||
3 months | +14.55% | ||
6 months | +247.59% | ||
Current year | +278.95% |
![Extreme 2.32](/images/extremecours_fleche.png)
![Extreme 0.61](/images/extremecours_fleche.png)
![Extreme 0.5042](/images/extremecours_fleche.png)
![Extreme 0.5042](/images/extremecours_fleche.png)
![Extreme 0.5042](/images/extremecours_fleche.png)
![Extreme 0.5042](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Salim Dhanji
CEO | Chief Executive Officer | 44 | 23-03-08 |
Quinn Martin
DFI | Director of Finance/CFO | 42 | 23-03-08 |
Jamil Kassam
SEC | Corporate Secretary | 44 | 23-03-08 |
Members of the board | Title | Age | Since |
---|---|---|---|
Karim Nanji
BRD | Director/Board Member | 57 | 23-06-06 |
Salim Dhanji
CEO | Chief Executive Officer | 44 | 23-03-08 |
Kenneth Harder
BRD | Director/Board Member | 57 | 23-03-08 |
Date | Price | Change |
---|---|---|
24-07-03 | 2.52 | +7.69% |
24-07-02 | 2.34 | 0.00% |
Delayed Quote Deutsche Boerse AG, July 03, 2024 at 09:29 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+21.90% | 45.01B | |
+47.19% | 40.96B | |
-5.84% | 38.62B | |
+35.41% | 32.6B | |
-8.34% | 27.49B | |
+17.33% | 27.17B | |
+48.77% | 14.61B | |
+40.95% | 12.95B | |
-2.22% | 11.36B |
- Stock Market
- Equities
- METX Stock
- Q9T Stock